Search details
1.
Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma.
N Engl J Med
; 386(4): 351-363, 2022 01 27.
Article
in English
| MEDLINE | ID: mdl-34904799
2.
Peripheral T-cell lymphoma: Are all patients high-risk?
Blood
; 2023 Dec 24.
Article
in English
| MEDLINE | ID: mdl-38142400
3.
Multicenter phase 2 study of oral azacitidine (CC-486) plus CHOP as initial treatment for PTCL.
Blood
; 141(18): 2194-2205, 2023 05 04.
Article
in English
| MEDLINE | ID: mdl-36796016
4.
Golidocitinib, a selective JAK1 tyrosine-kinase inhibitor, in patients with refractory or relapsed peripheral T-cell lymphoma (JACKPOT8 Part B): a single-arm, multinational, phase 2 study.
Lancet Oncol
; 25(1): 117-125, 2024 Jan.
Article
in English
| MEDLINE | ID: mdl-38092009
5.
A multi-cohort phase 1b trial of rituximab in combination with immunotherapy doublets in relapsed/refractory follicular lymphoma.
Ann Hematol
; 103(1): 185-198, 2024 Jan.
Article
in English
| MEDLINE | ID: mdl-37851072
6.
Final results of a phase II study of CHOEP plus lenalidomide as initial therapy for patients with stage II-IV peripheral T-cell lymphoma.
Br J Haematol
; 202(3): 525-529, 2023 08.
Article
in English
| MEDLINE | ID: mdl-37217196
7.
Hematological Oncology journal women in lymphoma special issue: Latest updates in nodal peripheral T-cell lymphoma.
Hematol Oncol
; 2023 Jun 13.
Article
in English
| MEDLINE | ID: mdl-37309261
8.
Evaluation of Breast Implant-Associated Anaplastic Large Cell Lymphoma With Whole Exome and Genome Sequencing.
Aesthet Surg J
; 43(3): 318-328, 2023 02 21.
Article
in English
| MEDLINE | ID: mdl-36351182
9.
CAR-modified memory-like NK cells exhibit potent responses to NK-resistant lymphomas.
Blood
; 136(20): 2308-2318, 2020 11 12.
Article
in English
| MEDLINE | ID: mdl-32614951
10.
An Updated Approach and Understanding of Breast Implant-Associated Anaplastic Large Cell Lymphoma.
J Natl Compr Canc Netw
; 20(3): 309-315, 2022 03.
Article
in English
| MEDLINE | ID: mdl-35276670
11.
T-Cell Lymphomas, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 20(3): 285-308, 2022 03.
Article
in English
| MEDLINE | ID: mdl-35276674
12.
Management of Peripheral T-cell Lymphomas and the Role of Transplant.
Curr Oncol Rep
; 24(11): 1489-1499, 2022 11.
Article
in English
| MEDLINE | ID: mdl-35947286
13.
Multicenter analysis of outcomes in blastic plasmacytoid dendritic cell neoplasm offers a pretargeted therapy benchmark.
Blood
; 134(8): 678-687, 2019 08 22.
Article
in English
| MEDLINE | ID: mdl-31243042
14.
Romidepsin and lenalidomide-based regimens have efficacy in relapsed/refractory lymphoma: Combined analysis of two phase I studies with expansion cohorts.
Am J Hematol
; 96(10): 1211-1222, 2021 10 01.
Article
in English
| MEDLINE | ID: mdl-34251048
15.
Clinical Trial of High-Dose Pegylated-Interferon-Alfa-2b Combined With Phototherapy in Advanced Stage Mycosis Fungoides.
J Drugs Dermatol
; 20(3): 349-350, 2021 03 01.
Article
in English
| MEDLINE | ID: mdl-33683074
16.
Management of relapsed/refractory classical Hodgkin lymphoma in transplant-ineligible patients.
Blood
; 131(15): 1698-1703, 2018 04 12.
Article
in English
| MEDLINE | ID: mdl-29500171
17.
How I treat breast implant-associated anaplastic large cell lymphoma.
Blood
; 132(18): 1889-1898, 2018 11 01.
Article
in English
| MEDLINE | ID: mdl-30209119
18.
NCCN Guidelines Insights: T-Cell Lymphomas, Version 1.2021.
J Natl Compr Canc Netw
; 18(11): 1460-1467, 2020 11 02.
Article
in English
| MEDLINE | ID: mdl-33152703
19.
NCCN Guidelines Insights: Primary Cutaneous Lymphomas, Version 2.2020.
J Natl Compr Canc Netw
; 18(5): 522-536, 2020 05.
Article
in English
| MEDLINE | ID: mdl-32380458
20.
A Cautionary Tale and Update on Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL).
Aesthet Surg J
; 40(12): 1288-1300, 2020 11 19.
Article
in English
| MEDLINE | ID: mdl-31894234